Celgene to buy Juno for $9 billion to boost CAR-T expertise

(Reuters) - Celgene Corp announced a $9 billion cash buyout of Juno Therapeutics Inc on Monday as it moves to cement its position as a key player in a new range of cancer therapies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news